Everyday foundations · Evidence Explainer
LIFTMOR improved bone density in a small supervised trial—not fracture prevention
The useful description is small, screened and supervised. Eight months of closely coached high-intensity resistance and impact training improved BMD and several functional measures versus home low-intensity exercise, but the trial did not establish fewer fragility fractures or general unsupervised safety.
Discovery, counterevidence, claim mapping, identifiers, funding, correction state and prose were reviewed before release.
Evidence box
Promising BMD and function findings under close supervision
- Study type
- Small randomized active-control exercise trial with vertebral-morphology follow-up
- Studied in
- Screened postmenopausal women with low bone mass; mean age 65
- Participants / sample
- 101 randomized; 43 per group in the reported per-protocol analysis
- Publication status
- Peer-reviewed primary and safety reports; retrospectively registered; published erratum retained
- Outcome type
- Bone-mineral density, strength, function, adherence, adverse events and vertebral morphology
- Development stage
- Completed research exercise protocol; not a standardized unsupervised program
- Conflicts / funding
- Griffith University and The Bone Clinic affiliations; later commercial translation disclosed
- Our assessment
- Promising supervised BMD and function results—not fracture prevention, universal safety or longevity evidence
- Reporting confidence
- High for bounded trial results; low for unsupervised, fracture or longevity generalization
Start here
Key takeaways
- Per-protocol lumbar-spine BMD changed +2.9% with HiRIT versus −1.2% with low-intensity exercise.
- Femoral-neck BMD changed +0.3% versus −1.9%, and several measured strength/function outcomes favored HiRIT.
- The trial was too small and short to establish fewer fragility fractures, mortality benefit, healthspan or lifespan extension.
Supervision is part of the intervention
Do not detach the result from screening and coaching.
What was studied
- Twice-weekly, 30-minute sessions progressed above 85% one-repetition maximum with impact loading.
- Participants were screened and closely supervised for eight months.
What was not established
- Safety or effectiveness of unsupervised high-intensity lifting in an unselected population.
- Reduction in fragility fractures, disability, mortality, healthspan or lifespan.
Evidence at a glance
BMD, function, safety and fracture are separate lanes.
Rows preserve what was measured; they are not a program score or exercise prescription.
| Outcome | Result | Boundary |
|---|---|---|
| Lumbar-spine BMD | +2.9% versus −1.2%. | Per-protocol biomarker outcome. |
| Femoral-neck BMD | +0.3% versus −1.9%. | Not a fracture endpoint. |
| Strength and function | Several measured outcomes favored HiRIT. | Specific tests in a small selected sample. |
| Safety and fracture | One minor back spasm; no incident vertebral deterioration in the assessed sample. | Insufficient for unsupervised safety or fracture prevention. |
The bottom line
LIFTMOR randomized 101 screened postmenopausal women with low bone mass to supervised high-intensity resistance and impact training or home-based low-intensity exercise. Per-protocol BMD and several function measures favored the supervised program. The trial did not establish fewer fragility fractures.
Why this matters
People with low bone mass are often warned away from heavy lifting, while promotional summaries can swing too far and imply that heavy training is universally safe. LIFTMOR is more specific: it tested a carefully progressed, coached protocol in selected volunteers.
What researchers did
The HiRIT group trained twice weekly for 30 minutes, progressing above 85% of one-repetition maximum and adding impact loading. The comparator performed home-based low-intensity exercise. The active comparison and close supervision are part of the result, not incidental details.
What they found
Among 43 per-protocol participants in each group, lumbar-spine BMD changed +2.9% versus −1.2% and femoral-neck BMD +0.3% versus −1.9%. Compliance was about 92% in HiRIT. Several strength and function measures also favored the program.
How strong is the evidence?
Randomization supports the measured group comparison, but the small sample, per-protocol emphasis, short duration, retrospective registry and selected volunteers limit certainty and generalization. BMD is useful but cannot substitute for a fracture endpoint.
What this evidence does not show
LIFTMOR did not establish fewer fragility fractures, lower mortality, longer healthspan or lifespan. One minor back spasm and no observed vertebral deterioration in a small assessed sample do not establish safety for unscreened or unsupervised training.
Safety, interpretation, and funding
The protocol involved screening, technique instruction and close supervision. Author affiliations included Griffith University and The Bone Clinic, and later commercial translation requires visible context. Clinic marketing is not independent efficacy evidence.
What happens next
Larger and longer trials can test fragility fractures, adverse events, adherence and transfer to broader populations. Comparisons should preserve the level of supervision and distinguish a reproducible protocol from the general idea of lifting heavily.
Primary sources
Sources, roles and limits
- LIFTMOR randomized trial
- Identifier
- PMID:28975661 · DOI:10.1002/jbmr.3284 · ACTRN12616000475448
- Role
- Primary randomized support
- Limitation
- Small, selected, supervised sample with per-protocol outcome emphasis.
- Vertebral-morphology and safety analysis
- Identifier
- PMID:30612163 · DOI:10.1007/s00198-018-04829-z
- Role
- Bounded safety and morphology context
- Limitation
- Not powered to establish fracture prevention or unsupervised safety.
- Published LIFTMOR erratum
- Identifier
- PMID:30861219 · DOI:10.1002/jbmr.3659
- Role
- Correction notice
- Limitation
- Corrects named table details; does not create a new efficacy outcome.
- ANZCTR record
- Identifier
- ACTRN12616000475448
- Role
- Registry identity
- Limitation
- Retrospective registration is a maturity limitation and not validation.
Connected topics
Continue through the knowledge system
Continue with real coverage
Keep reading
These are learning paths, not rankings, recommendations, or evidence that the stories support one another.
A broader map of exercise outcomes and evidence maturity
Exercise has strong evidence for function—not proof of slower biological aging
Human trials support mobility and physical function in defined populations. Lifespan and biological-age claims require separate evidence.
Evidence scopeHuman function · mature randomized evidence
A larger trial centered on mobility disability
Structured physical activity reduced late-life mobility disability—not aging itself
LIFE supports a meaningful mobility outcome in vulnerable older adults, while lifespan and universal-program claims remain untested.
Evidence scopeHuman function · randomized trials
A supplement-plus-training evidence question
Creatine added to resistance training may improve some strength measures—not longevity
Pooled short trials found modest lean-mass and strength gains, while a related one-year analysis found no additional benefit.
Evidence scopeHuman function · trials and pooled evidence
Disclosures and history
- August 2, 2026 — source discovery, verification and counterevidence completed before prose drafting.
- August 2, 2026 — atomic claim map, supervision boundary, funding and prose reviewed.
- March 11, 2019 — published erratum corrected table headings and the calcium-intake-change sign without reversing a bone or fracture outcome.